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National Advisory Committee on Drugs (NACD) 
Vision, Mission, Values 
 
Vision 
To provide a national focus for all knowledge related efforts that inform Irish policy in relation to 
drug misuse. 
 
Mission  
The NACD has undertaken to: 
• Support the Government in significantly reducing the health, social and economic 
consequences of drug misuse through the provision of timely data and analysis of 
research; 
• Review its knowledge base, identifying gaps which can be addressed through research; 
• Ensure that evidence from scientific research forms the basis for policy formulation, 
development of services and continuous improvement in all its approaches to tackling 
drug misuse in Ireland;  
• Work closely with the Evidence Generation and Knowledge Brokering Unit (formerly 
ADRU) of the Health Research Board, providing advice, coordinating research efforts 
and maximising the use of resources;  
• Support the establishment of a National Documentation Centre;  
• Liaise with the relevant agencies nationally in order to co-ordinate research and 
resources;  
• Ensure participation nationally of a broad range of parties in fulfilling its research needs 
and dissemination of findings;  
• Serve all drug misuse reduction activities in providing for an effective dissemination of 
research findings, information and other data thus linking research to practice.  
Values 
The NACD agreed that the following values would guide the implementation of its work 
programme. The NACD will: 
• Manage the diversity of its membership and commit to a consensus approach in 
decision-making; 
• Foster a culture of respect, dignity, transparency and fairness in all its operations;  
• Advocate dialogue as a means of balancing the diverse views on and experiences of drug 
misuse in Ireland ; 
• Be objective in the collection and dissemination of information in line with its 
commitment to the National Drugs Strategy (NDS) 2001-2008, and subsequently 2009-
2016 Interim NDS ; 
• Commit to the highest possible standards of excellence and ethical conduct;  
• Seek out collaborations and partnerships where there is greater benefit to achieving its 
goal and co-operate with everyone who can benefit from its knowledge base. 
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FOREWORD 
 
It gives me great pleasure to welcome the 2009 Annual Report of the National 
Advisory Committee on Drugs (NACD).   
 
The NACD fulfils a very important role in providing research-based advice to 
Government in relation to drug use across the island of Ireland.  During 2009 a 
new National Drugs Strategy for the period 2009-2016 was agreed and the 
mandate of the NACD was renewed.   
 
Notable achievements in 2009 include the publication of a Study entitled “Drug 
Use, Sex Work and the Risk Environment in Dublin”, and the publication of the 
final report of “The ROSIE Study: Drug Treatment Outcomes in Ireland” which 
established the impact of methadone treatment on the health of individuals and 
on offending behaviour.   
 
I want to congratulate the Chairman, Dr. Des Corrigan, the Director, Ms. Susan 
Scally, and the members of the Committee for their enthusiasm and commitment 
to the work of the NACD. As well as this, the work of the NACD is greatly 
enhanced through the engagement of a significant number of people, from a 
wide field of expertise, on its various sub-committees and research advisory 
groups.  I wish to thank them and the staff of the NACD. 
 
Pat Carey T.D. 
Minister for Community, Equality and Gaeltacht Affairs 
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CHAIRPERSON’S REPORT 
 
The year 2009 was a very challenging one for the NACD because the Committee 
had to absorb the loss of its Research Officer, Dr Gemma Cox and a researcher, 
Dr Teresa Whittaker, both of whom had made enormous contributions to our 
work and it is still a matter of huge regret that we were not permitted to renew 
their contracts. The loss of the skills and experience of two outstanding 
researchers had a very serious and damaging effect on the subsequent work of 
the NACD which was further aggravated by a significant budget cut. The fact 
that we still managed to publish significant reports on “Drug Use, Sex Work and 
the Risk Environment in Dublin” and the Final Report of the ROSIE Study as 
well as finalising studies on Early School Leavers and on Drug Markets is 
testimony to the hard work and commitment of the NACD and its remaining 
staff. 
 
An additional challenge arose from the adoption of the interim National Drugs 
Strategy (2009-2016) which, in renewing the mandate of the NACD up to the end 
of 2011, provided us with a significant number of new work areas. As a result, a 
new Work Programme for the next two years has been agreed with the Office of 
the Minister for Drugs (OMD), but the NACD will need the requisite in-house 
technical and research capability as well as adequate financial support in order to 
meet the targets set for us by the Government’s National Drugs Strategy. 
Detailed planning for the implementation of that work programme did 
commence during 2009 and I wish to acknowledge in particular the painstaking 
work of Dr Jean Long and Dr Deirdre Mongan of the former ADRU at the HRB, 
in assisting the staff of the NACD prepare for the Population Survey 2010/2011, 
the fieldwork for which is scheduled to begin in autumn 2010. 
 
The varied and extensive work of the Committee would not be possible without 
the expertise and commitment of those who serve on the NACD, its sub-
committees and research advisory groups. Members give unselfishly of their 
time and knowledge and they represent a unique national resource which should 
not be lightly discarded at the present time. I am deeply indebted to all of them 
for their contributions to the success of the NACD to date. In particular I wish to 
acknowledge the work of those members of the Committee who retired during 
2009 namely; Ms Jackie Blanchfield, Ms Anna Quigley, Ms Mary O’Shea, Ms 
Mairead Kavanagh, Ms Vivienne Fay, Mr Eamon Corcoran and Supt. Barry 
O’Brien and to thank them for their input into the work. I also want to record my 
appreciation of the support I have received from the Vice-Chair, Dr Mary Ellen 
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McCann and to the chairs of the various sub-committees; Mr Liam O’Brien, Mr 
Eamon Corcoran, and Dr Eamon Keenan. 
 
My colleagues and I are deeply indebted to the staff of the NACD who work 
incredibly hard to ensure that the outputs of the Committee are of the highest 
quality. I want to put on record my appreciation and that of my colleagues of the 
efforts the staff have made to keep the show on the road over the past year 
particularly during the disruptive relocation of the NACD offices from 
Shelbourne House to Dún Aimhirgin in Mespil Road. I also want to pay a special 
tribute to the interim Director, Ms Susan Scally who joined the NACD at a very 
difficult time but who has managed the challenges facing the Committee in a 
sensitive and professional manner. 
 
The continued support of the Minister and his officials in the then Drugs Strategy 
Unit and now in the new OMD, for the work of the NACD, is welcome and has 
been an essential element in the success of the Committee since its establishment 
in July 2000. As we face into the challenges presented by the new Work 
Programme, I am hopeful that with the continued support of the Minister and 
the OMD, the NACD can fulfill its remit as “the research arm of the National 
Drugs Strategy”. 
 
Dr Des Corrigan FPSI 
Chairperson. 
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EXECUTIVE SUMMARY  
 
2009 has been a challenging year for the NACD with the departure of two 
experienced researchers and a secretary. Despite these setbacks, it was a busy 
year for the NACD. There have been seven full Committee meetings; 13 sub-
committee meetings and 13 Research Advisory Group meetings culminating in 
the production of 10 publications, five of which were web-only publications.    
These achievements could not have been realised without the commitment, 
dedication and enthusiasm of the members of the NACD and its five sub-
committees. 
 
During the year, the NACD relocated its offices from Shelbourne House to the 
same building as the newly established Office of the Minister for Drugs in Mespil 
Rd, Dublin 4.  We look forward to working closely with the new Office to create 
improved linkages between policy development and research. 
 
A major achievement of 2009 was the production of the “Drug Use, Sex Work 
and the Risk Environment in Dublin” study.  The findings of this report highlight 
that drug-using sex workers are exposed to multiple risks and harms in their 
lived and working lives. The report found that addressing their wider social and 
situation needs such as poverty, housing, health, education needs and 
employment prospects are as fundamental to reducing their risk of harm as 
addressing their drug use.  The key findings of the research were presented in a 
seminar attended by over 100 stakeholders in June. 
 
The NACD is staffed by a small team of very hard-working and adaptable 
people who have been a great support to me in my first year with the NACD. I 
am very grateful to Alan Gaffney, the NACD Office Manager and to Mary Jane 
Trimble who provides reception and secretariat support to the NACD, for their 
hard work and commitment this year. I would also like to acknowledge the 
contribution made by Dr Gemma Cox, the NACD Research Officer; Dr Teresa 
Whitaker, Researcher and Ms Sheena Duffy providing part-time administrative 
support, whose employment with the NACD ceased during 2009.    
 
Susan Scally 
Director
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GLOSSARY OF TERMS 
 
C&AG   Comptroller and Auditor General 
 
DAG    Drugs Advisory Group 
 
DTMS    Drug Trend Monitoring System 
 
ED    Electoral Division 
 
EGKBU                                      Evidence Generation and Knowledge Brokering Unit  
    (formerly ADRU) 
  
FOI    Freedom of Information 
 
HIV    Human Immunodeficiency Virus 
 
HRB    Health Research Board 
 
HSE    Health Service Executive 
 
IAAAC Irish Association of Alcohol and Addiction Counsellors 
 
IDG Inter Departmental Group on Drugs 
 
LDTF Local Drugs Task Force 
 
MQI Merchants Quay Ireland 
 
NACD National Advisory Committee on Drugs 
 
NHISU National Health Information Systems Unit 
 
NVDS National Voluntary Drug Sector 
 
NDS National Drugs Strategy 
 
NUI National University of Ireland 
 
OFD Oversight Forum on Drugs 
 
OJEU Official Journal of the European Union 
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OMD Office of the Minister for Drugs 
 
PHIRB Public Health Information and Research Branch 
 
PQ Parliamentary Question 
 
RAG Research Advisory Group 
 
RDTF Regional Drugs Task Force 
 
RIWG Research and Information Working Group 
 
ROSIE Research Outcome Study in Ireland evaluating drug 
treatment effectiveness 
 
UCD University College Dublin 
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Chapter One 
 
Background and Functions of the NACD 
 
1.1 Origins 
 
The NACD was established in July 2000 to advise the Government on problem 
drug use in Ireland in relation to consequences, prevalence, prevention, and 
treatment including rehabilitation, based on its analysis and interpretation of 
research findings and information available to it.  It also provides ‘early warning’ 
advice to Government. The Committee comprises representation from 
Government Departments, Academia, Community, Voluntary and Statutory 
sectors and reports to the Minister of State with responsibility for the National 
Drugs Strategy. Further information can be obtained from the website 
www.nacd.ie. 
 
Arising from a Government decision to renew the NACD mandate in 2004, a 
further work programme was developed. A consultation process was 
undertaken with key interest groups and stakeholders to explore further research 
and information opportunities. The business plan developed incorporates the 
continuation of the current programme and identifies ongoing gaps in 
knowledge.  The business plan was approved by the Cabinet Committee on 
Social Inclusion and is published on the NACD website (“Business Plan 2005-
2008”).  Research undertaken by the NACD during 2009 relates primarily to 
actions set out in the National Drugs Strategy 2001-2008.      
 
Further to Government approval during 2009 of proposals for a new National 
Drugs Strategy (interim) 2009-2016, the NACD mandate was extended until the 
end of 2011 and work began on developing a new work programme. This 
involved a consultation process with members of the five sub-committees of the 
NACD. The key priorities of the work programme for 2010-2011 were 
determined at a planning session of the NACD in November 2009. The work 
programme was agreed with the Minister of State with responsibility for the 
Drugs Strategy, the Office of the Minister for Drugs and the NACD in December 
2009.  
 
Over the years the NACD has worked closely with other agencies and 
organisations to optimise skills and resources in gathering information and 
filling gaps in knowledge.  In particular, the NACD works closely with the 
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Health Research Board’s Evidence Generation and Knowledge Brokering Unit 
(formerly Alcohol and Drugs Research Unit) on meeting the information needs 
of the EU Five Key Indicators of Drug Use.  The NACD is engaged in ongoing 
collaborative work with colleagues in the Public Health Information and 
Research Branch of the Department of Health, Social Services and Public Safety 
in Northern Ireland, gathering information on drug prevalence amongst the 
general population on the whole island. 
 
The work programme and modus operandi of the NACD is an evolving process 
and further information can be obtained on the NACD website.  However, its 
core functions were set down by Government in 2000 and these have not altered 
– see over. 
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1.2 Functions 
 
On its establishment in 2000, the functions of the NACD (the Committee)  were 
set out as follows: 
 
• Based on the Committee’s analysis and interpretation of research findings 
and information available to it, to advise the Cabinet Committee on Social 
Inclusion and, through it, the Government, in relation to the prevalence, 
prevention, treatment and consequences of problem drug use in Ireland; 
• To review current information sets and research capacity in relation to the 
prevalence, prevention, treatment and consequences of problem drug use 
in Ireland and to make recommendations, as appropriate, on how deficits 
should be addressed including how to maximise the use of information 
available from the community and voluntary sector; 
• To oversee the delivery of a three-year prioritised programme of research 
and evaluation as recommended by the Interim Advisory Committee to 
meet the gaps and priority needs identified; by: 
 
a)  using the capacity of relevant agencies engaged in information 
gathering and research, both statutory and non-statutory, to deliver 
on elements of the programme; 
b)  liaising with these agencies with a view to maximising the resources 
allocated to delivering the programme and avoiding duplication; 
c)  co-ordinating and advising on research projects in the light of the 
prioritised programme; 
d)  commissioning research projects which cannot be met through 
existing capacity; 
e)  commissioning additional research at the request of the Government 
into drug issues of relevance to policy. 
 
• To work closely with the Health Research Board (HRB) on the 
establishment of a national information/research database (in relation to 
the prevalence, prevention, treatment and consequences of problem drug 
use) which is easily accessible; and 
 
• To advise relevant Agencies with a remit to promote greater public 
awareness of the issues arising in relation to problem drug use and to 
promote and encourage debate through the dissemination of its research 
findings.  
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Chapter Two 
 
Structures and Work Programme 
 
2.1 Structures  
 
2.1.1 The NACD 
 
The NACD comprises 19 members who, with the exception of the Chairperson, 
participate on a voluntary basis.  Since 2005, the Chairperson receives a small 
honorarium. Members serve at the invitation of the Minister of State and their 
participation requires them to sit on the NACD main committee and at least one 
sub-committee.  NACD meetings are generally scheduled to take place every six 
weeks excluding July and August.  In 2009, five standard meetings, one planning 
meeting and one emergency meeting to consider the implications of the staffing 
situation in the wake of the non renewal of the Research Officer’s contract, were 
held.  Full membership is detailed in Appendix 1. 
 
2.1.2 Sub-Committees 
 
Due to the complexity of the drugs issue the NACD manages its work 
programme through sub-committee structures including research advisory 
groups (RAGs).  There are five sub-committees in operation: Consequences; 
Early Warning Emerging Trends; Prevalence; Prevention; and 
Treatment/Rehabilitation.  Each committee meets as required and according to 
the needs of the NACD work programme.  In 2009, a total of 13 sub-committee 
meetings were held as follows: Consequences (2); Early Warning Emerging 
Trends (3); Prevalence (4); Prevention (1); and Treatment/Rehabilitation (3). 
There were a total of 13 RAG meetings in 2009. Full sub-committee membership 
is detailed in Appendix 2. 
 
2.1.3 Terms of Reference 
 
Terms of Reference for sub-committees and research advisory groups are 
available on the NACD website. 
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2.2 Work Programme of NACD 
 
In 2001, the NACD published its first work programme and a business plan was 
published in 2002.  The NACD was externally reviewed by Talbot Associates in 
2004 and this led to Government approving a renewed mandate to the end of 
2008. A three-year business plan was published in 2005. This set out a new work 
programme incorporating projects from earlier work programmes that had still 
to be completed and research that needed to be repeated. Accordingly, research 
undertaken by the NACD during 2009 relates primarily to actions required of the 
NACD under the National Drugs Strategy 2001-2008. These actions are set out in 
Appendix 3 of the report.   
 
Arising from a Government decision in June 2009 approving proposals for a new 
National Drugs Strategy (interim) 2009-2016, the NACD mandate was extended 
until 2011.  The actions for which the NACD has lead responsibility are set out in 
Chapter 7 of the new Strategy.  Further information is available on the website of 
the Office of the Minister for Drugs www.pobail.ie. In light of the research and 
information priorities identified in the Strategy, the development of a new 
NACD work programme to cover the period up to 2011 was advanced in the 
latter part of 2009.    
 
In 2009, one new research project was commissioned and there were eight, 
ongoing research projects. A total of 10 publications was achieved; five of which 
were web-only publications with the remainder printed and distributed.   
 
2.2.1 Summary of 2009 
 
The ongoing work programme in 2009 comprised the following: 
 
 Analysis of data from the 2006/2007 Drug Prevalence Survey culminating 
in the publication of Bulletins 5 & 6 and Confidence Intervals for Bulletin 2;  
 Publication of the Final ROSIE Report;  
 Ongoing  data analysis on drug use and prostitution research culminating 
in the production of the final report ‘Drug Use, Sex Work and the Risk 
Environment in Dublin’; 
 Ongoing data analysis on a comparative study of drug use amongst early 
school leavers and attendees ;  
 Repeat Capture Recapture Study Report finalised and published; 
 Research into drug markets in Ireland; 
 Planning of the 2010-2011 Drug Prevalence Survey. 
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Externally commissioned research: 
 
 Drafting of the final report on the Early School Leaver Study. 
 
Internal work – summary of activities: 
 
 Early School Leaver Study –  ongoing monitoring of data analysis, tender 
issue/evaluation for report write up – all managed internally; 
 Drug Markets Study –  ongoing monitoring and support; 
 Drug Users, Sex Work and the Risk Environment in Dublin –  completion 
of  writing of report, publication of final report, organisation of seminar 
and launch of  report –  all managed internally; 
 Drug Prevalence Surveys –  prepared and published two bulletins, 
prepared confidence intervals (CIs) for bulletin 2 (06/07 survey) and 
updated 2002/3 CIs; 
 Review and guidance to research team on ROSIE Final publication ; 
 NDS Review – meetings and consultations attended; 
 Monitoring and support to the research team on the repeat Capture 
Recapture Study; 
 Feedback to the Oversight Forum on Drugs;  
 Prepared the 2008 Annual Report and published it on the web; 
 Maintenance of the website and ongoing Irish translation of relevant 
uploads to website; 
 Organised move to new premises.  
  
2.2.2 The Research Process 
 
All research has the support of a Research Advisory Group (RAG).  The Terms of 
Reference for these RAGs have been noted in previous reports and are now 
available on the website. The RAG comes together once the research question has 
been decided and a commissioning process must be embarked upon.  Research is 
externally contracted via requests for tenders, direct engagement or internal 
action. The RAG, which generally comprises relevant stakeholders or experts, 
oversees the research process, coaching and mentoring the researchers, advising 
and guiding when appropriate and reviewing written output before finally 
signing off on a report for consideration by the NACD. 
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2.2.3 Commissioned Research 
 
One research project was commissioned in 2009 and preliminary work started on 
the 2010/2011 Drug Prevalence Survey, as outlined below: 
 
 (i)  Risk and Protection Factors for Substance use among Young People: 
A comparative study of early school leavers and school attending 
students 
 
The NACD acted as Principal Investigator in this internally designed 
study.  The NACD received ethical approval for the study implementation 
from the Drug Treatment Centre Board Research Ethics Committee. The 
study is examining drug use among early school leavers and school 
attendees in the context of risk and protective factors. Following 
completion of the pilot study, a tender issued for the fieldwork element of 
the main study and this was awarded to Ipsos MORI. Fieldwork was 
completed in 2008. Following an initial analysis of the survey data, 
completed in 2009, the NACD commissioned an external researcher to 
draft a report on the results of the research.  The final results of the study 
were presented to the NACD in December. 
 
 (ii) Drug Use in Ireland and Northern Ireland 2010/2011 Drug 
 Prevalence Survey  
 
Arising from a Government Decision of 31 March 2009, the Office of the 
Minister for Drugs and the Department of Health and Children are 
currently developing a National Substance Misuse Strategy to be 
completed in 2010 to cover the period 2011-2016. Up-to-date data for 
planning population-based responses to alcohol and other drugs will be 
required to implement the new strategy in 2011/2012. Accordingly, new 
questions are being included in the 2010/2011 Drug Prevalence Survey to 
measure alcohol use, dependency and related harms. New questions are 
also being included to measure cannabis dependency and use of ‘Head 
Shop’ drugs.  The NACD received ethical approval for the survey from 
the Research Ethics Committee of the Faculties of Public Health Medicine 
and Occupational Medicine.  A request for expressions of interest to carry 
out the fieldwork phase of the survey was placed in the Official Journal of 
the European Union in December 2009.  
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2.2.4 Ongoing Research     
 
(i) Drug Use in Ireland and Northern Ireland 2006/2007 Drug Prevalence 
Survey  
 
This series of Bulletins presents the key findings from the second drug 
prevalence survey of households in both Ireland and Northern Ireland.  A 
representative sample of people aged between 15 and 64 years was 
surveyed during late 2006/early 2007, according to the standards set by 
the European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA). The data in these bulletins relate to drug prevalence rates on 
a lifetime, last year (recent) and last month (current) basis for illegal and 
other drugs including alcohol and tobacco. Statistically significant 
differences in prevalence rates between 2002/3 and 2006/7 are also 
presented. Close collaboration with colleagues in Northern Ireland took 
place to ensure matching standards and to develop joint publications of 
the data for both jurisdictions. There were five publications in 2009: 
 
Drug Use in Ireland and Northern Ireland: Updated Results from the 
2002/2003 Drug Prevalence Survey: Bulletin 1: UDATED CONFIDENCE 
INTERVALS.  Published on the web only in February 2009; 
 
Drug Use in Ireland and Northern Ireland: Updated Results from the 
2002/2003 Drug Prevalence Survey: Health Board (Ireland) and Health 
and Social Services Board (Northern Ireland): Bulletin 2: CONFIDENCE 
INTERVALS. Published on the web only in February 2009; 
 
Drug Use in Ireland and Northern Ireland 2006/2007 Drug Prevalence 
Survey: Regional Drugs Task Force (RDTFs) Results: Bulletin 2: 
CONFIDENCE INTERVALS. Published on the web only in February 
2009;  
 
Drug Use in Ireland and Northern Ireland 2006/2007 Drug Prevalence 
Survey: Sedatives or Tranquillisers, and Anti-depressants Results: 
Bulletin 6.  Published in March 2009; 
 
Drug Use in Ireland and Northern Ireland 2006/2007 Drug Prevalence 
Survey: Polydrug Use Results: Bulletin 5.  Published in June 2009. 
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(ii) The Research Outcome Study in Ireland Evaluating Drug Treatment 
 Effectiveness (ROSIE Study)  
 
In 2002 the NACD commissioned the ROSIE Study under Action 99 of the 
National Drugs Strategy 2000-2008. It is the first national, prospective 
longitudinal  multi-site drug treatment outcome study in the country.  The 
Study recruited and followed up on 404 opiate users, from the 
commencement of a new treatment episode (treatment intake) and 
monitored progress at time-anchored points: 6 months; 1-year; and 3 years 
after treatment intake. The participants were recruited on entry into three 
different types of treatment: methadone maintenance (53.2%); structured 
detoxification (20%); and abstinence-based treatment (20.3%); and a sub-
sample of opiate users were recruited from needle-exchange facilities 
(6.4%). 
 
Four ROSIE Findings bulletins were published in 2007, the first (ROSIE 
Findings 1) reported on the outcomes at 1-year for drug-use, involvement 
in crime, injecting-related risk behaviour, and physical and mental health 
outcomes. The subsequent three bulletins (ROSIE Findings 2, 3 and 4) 
reported on the 1-year outcomes for each method of treatment 
(detoxification, abstinence, and methadone).   
 
Further analysis of the ROSIE data for 1-year and 3-year outcomes was 
ongoing at the end of 2007 and a further three ‘ROSIE Findings’ bulletins 
were published in 2008. ROSIE Findings 5 provided analysis of the 
similarities and differences by gender at 1-year follow-up and was 
published in October 2008. ROSIE Findings 6 presented a summary of 3-
year outcomes for the whole study population (follow-up rate of 88%) 
described as those who completed interviews at intake and 3 years.  This 
was published on the website only in October 2008. 
 
ROSIE Findings 7 presented findings for those who completed all three 
interviews (follow-up 72%) at intake to treatment, at 1-year follow-up and 
at 3-years. These participants are referred to as the ‘Per Protocol’ group. 
This was published in October 2008. These publications are available on 
the NACD website www.nacd.ie 
 
The ROSIE Study: Drug Treatment Outcomes in Ireland, the final report 
in the ROSIE series was published and disseminated in June 2009. This 
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report provides a comprehensive overview of the study and presents 
treatment intake data and outcomes at 1-year and 3 years. 
 
In 2008, the NACD also commissioned a DVD to tell the story of Drug 
Treatment Outcomes in Ireland and this was completed in December. The 
DVD was distributed along with the final ROSIE report.  
 
 (iii) Exploring the Risk Environment of Problematic Drug Users who 
 Engage in Prostitution in Dublin 
 
The NACD acted as Principal Investigator in this study. It was designed 
internally and received ethical approval for its implementation from the 
Drug Treatment Centre Board Research Ethics Committee. Data were 
analysed and interpreted and a first draft of the report was sent to the 
NACD in December 2008. The final report was launched, published and 
disseminated in May 2009. A seminar was hosted by the NACD in June 
2009 to discuss the outcomes of the report with stakeholders. 
 
(iv)  Drug Markets Study 
 
The Health Research Board was commissioned to conduct a study on the 
illicit drug markets in Ireland in order to address a gap in available 
research in this area. The study is intended to examine the factors which 
can influence the development of local drug markets, the nature, 
organisation, and structure of Irish drug markets and the impact of drug 
dealing and drug markets on local communities. It is hoped that the 
research will assist in furthering the objectives and key performance 
indicators outlined under the supply reduction pillar of the National 
Drugs Strategy. Qualitative interviewing and analysis of data collated in 
relation to the research sites was completed during 2009.  An initial draft 
of the final report was presented to the NACD in December 2009. 
 
(v)  Repeat Capture Recapture Study 
 
This is a repeat of the Capture Recapture Study which provided estimates 
on the prevalence of problem opiate use in Ireland for the period 2000 to 
2001 using three data sources: the Central Treatment List, Garda PULSE 
data and the HIPE (Hospital In-Patient Enquiry) database. The aim of the 
repeat study is to provide updated estimates based on data for the period 
2006. Dr Alan Kelly from the Small Area Health Research Unit (SAHRU), 
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Trinity College Dublin was contracted to draft the report, which was 
published in December 2009. 
 
2.2.5 Collaboration 
 
Collaborative working is a core principle of the NACD and every effort is made 
to involve stakeholders at various levels in relevant discussions, research projects 
and research activities.  Over the last year the NACD has been very active in 
collaborating with colleagues in Northern Ireland on the third All Ireland Drug 
Prevalence Survey.  This joint working relationship has continued since 2002.  In 
addition, the NACD convened relevant stakeholders in the various RAGs to 
support other research projects. They involve officials from the Departments of 
Education and Science; Justice, Equality and Law Reform; Health and Children; 
The Health Service Executive; The Health Research Board; Office of the Minister 
for Drugs; UCD; Trinity College; National Youth Council of Ireland; Crosscare 
Drug and Alcohol Programme; Ruhama; Chrysalis; UISCE; Women’s Health 
Project; Gay Men’s Health Project; Dublin Aids Alliance; Gay HIV Strategies; An 
Garda Síochána; The Forensic Science Laboratory; and The Customs Drugs Law 
Enforcement Unit of The Revenue Commissioners. 
 
2.3 Performance Management 
 
2.3.1 Staff  
 
The NACD has four core posts supported directly through secondment and 
contract by the Department of Community, Rural & Gaeltacht Affairs. The 
NACD Director post has been filled on secondment by a Principal Officer from 
the Department of Community, Rural and Gaeltacht Affairs since early February 
2009. A Higher Executive Officer and Clerical Officer are presently seconded 
from the Department. The Research Officer (contract post) position is currently 
vacant. 
 
2.3.2 Balanced Scorecard 
 
In 2009 the NACD had an efficiency rate of 64%. This is lower than in previous 
years due to a combination of the office re-location, budget cuts and especially 
staff losses. There were 17 internal meetings (five of which were team meetings) 
held to manage the flow of work and to maintain the high levels of productivity 
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from such a small team.  The remaining 12 meetings related to the work of sub- 
committees, RAGs and visitors to the NACD.  
 
Briefings to the Minister were provided on five occasions and 22 external 
meetings were attended, relating to the provision of support to other agencies 
and to the research programme of the NACD. The committee was also 
represented at meetings of the IDG and the new Oversight Forum on Drugs 
(OFD) 
 
In addition to commissioning and managing its research, the NACD work 
programme generates a range of other activities which adds another project 
management dimension to the operations of the NACD.  Internal work includes 
providing secretariat support to the various committees, organising events, 
media relations and managing the publication process (which involves proofing, 
editing, checking in great detail all drafts going to and coming from the design 
house and co-ordinating the printing process). Each publication generates a 
series of activities related to planning and organising the dissemination of 
reports, and in 2009 over 7,504 reports were circulated to key stakeholders.   
 
2.3.3 Freedom of Information (FOI) 
 
The NACD makes most of its information available on-line. Nonetheless, it 
receives FOI requests from time to time. A reference book has been published on 
the website in accordance with the requirements of Sections 15 and 16 of the FOI 
Acts. In accordance with Section 15 of the Act, the purpose of this reference book 
is to facilitate access to official information held by the NACD, by outlining the 
structure, functions and details of the services provided by the NACD, how they 
may be availed of, information on the classes of records held, and information on 
how to make a request to the NACD under the Freedom of Information Acts, 
1997 and 2003. Section 16 of the FOI Act requires the NACD to publish a book 
containing the rules, procedures, practices, guidelines and interpretations used 
by the NACD. Copies of this publication are available at www.nacd.ie and upon 
request from the offices of the NACD. 
The FOI Officer at the NACD is Mary Jane Trimble. Alan Gaffney is the FOI 
Decision Maker and internal appeals are dealt with by the Director.  There were 
no FOI requests in 2009. 
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2.3.4 Office of the Minister for Drugs (OMD) Support  
 
The NACD provided information in response to Parliamentary Questions (PQs) 
to the OMD, at the Department of Community, Rural & Gaeltacht Affairs and 
provided other information in response to general queries on drug issues 
throughout 2009. The OMD supported the NACD in the preparation and signing 
of contracts and in the administration of financial resources allocated to NACD.   
 
2.3.5 Participation in Training 
 
Ongoing professional development of staff continued in 2009 through 
participation in various seminars and conferences and through participation on 
specific courses agreed through the professional development plan. These 
courses covered the areas of: 
 
 Editing & Proof Reading; 
 Media Training. 
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Chapter Three 
 
Communications 
 
The core functions of the NACD require a commitment to communications in its 
broadest sense to promote and encourage debate and discussion of drug issues 
internally and externally amongst the wide range of stakeholders who interact 
with it. The publication and distribution of NACD research is a further 
dimension to using communications tools in achieving goals. The objectives of 
the communications strategy are: 
• To provide timely advice and briefings to the Minister on key issues and 
emerging trends; 
• To advise service providers and practitioners across sectors of relevant 
research findings that may inform current thinking and practice; 
• To promote the research agenda amongst key influencers in those 
agencies and bodies that promote, commission, fund or undertake drug-
related research and/or have access to relevant data in this field;  
• To represent the NACD and Ireland at international fora. 
3.1 Advice to Government 
 
The NACD provided advice to Government on several occasions during 2009 
through its participation on the IDG and subsequently the Oversight Forum on 
Drugs, in its briefings with the Minister and through recommendations made 
based on research or information it had considered.  In 2009 this advice covered 
the areas of drug treatment outcomes, prevalence of sedatives and tranquillisers, 
polydrug use, harm reduction, and prevalence of opiate use. The NACD also 
provides ongoing advice and support to the Office of the Minister for Drugs in 
responding to parliamentary questions and general queries. 
 
3.2 Media Relations 
 
In 2009 the NACD continued to generate considerable media interest. The launch 
of the report on “Drug Use, Sex Work and the Risk Environment in Dublin” was 
attended by a broad range of media representatives, with the Minister, 
Chairperson, and other NACD members participating in interviews on various 
issues arising from the research. 
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NACD publications generate instant news coverage and in 2009 the NACD was 
mentioned in news bulletins on television, across 20 local radio stations 
including four independent stations in Dublin, and on RTE One; 2FM; Today 
FM; and Newstalk Radio. Twenty three interviews were given on national and 
regional radio and television news and current affairs programmes including 
programmes on RTE One; 2FM; Newstalk Radio; FM104; Today FM; and nine 
other local and regional channels.  
  
Nineteen articles relating to publications released by the NACD or research 
carried out by the NACD appeared in national newspapers including: The Irish 
Times; Irish Examiner; Irish Independent; Sunday Business Post;  Daily Star; Irish 
Daily Mirror; Herald AM;  and Metro. There were a further 10 articles published 
on eight web based media sites.  
 
3.3 NACD Website 
 
The website contains all the necessary information about the NACD, including 
its vision, mission, values, functions and membership. Information on the sub-
committee structure and the NACD’s programme of work is also included. 
 
The site has been restructured to make it more user-friendly and has been 
updated to include the research projects, events and seminars which took place 
in 2009 and in previous years. Additional links have been added to the website. 
 
All NACD reports are published simultaneously on the website and can be 
downloaded free of charge.  The website is in bilingual format - English and Irish 
- thus Irish versions of annual reports, business plans, press releases and research 
summaries dating from 2003 can be downloaded.  
 
3.4 Seminars /Conferences organised by NACD staff in 2009 
 
NACD Conference “Drug Use Sex Work and the Risk Environment in Dublin”   
Coach House, Dublin Castle 18th June 2009 
 
The aim of the conference was to present the key findings of the research ”Drug 
Use, Sex Work and the Risk Environment in Dublin” to service providers and 
agency workers who work directly or indirectly with this group of drug users.  
Minister John Curran opened the conference and Dr Teresa Whitaker, (NACD) 
presented findings and recommendations from the report. Invited speakers 
included Dr Linda Cusick, Reader in Substance Use at the University of West 
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Scotland and Ms Katherine McGarry from Trinity College Dublin who presented 
papers on key aspects of recommendations contained in the report. 
 
3.4.1 Seminars /Conferences attended by NACD staff in 2009 
 
February 
 
Seminar: Crack Cocaine – Health Research Board 24th February 2009 
 
Seminar: SPSS User Conference (SPSS is a statistical analysis package) – SPSS 
Ireland  
 
June 
 
Conference: Dignity Conference – Women’s Health Project  
 
Sex Trafficking and Prostitution: The Dilemma of Demand – Immigrant Council 
of Ireland  
 
September 
 
Conference: Bridging the Research Gap in the Field of Illicit Drugs in the EU, 
hosted by European Commission, Brussels  
 
3.4.2 Presentations given by the Research Team during 2009 
  
March  
 
Presentation on Drug Use Sex Work and the Risk Environment in Dublin to the 
Interdepartmental Group on Drugs, by Dr Teresa Whitaker 
 
April 
 
Presentation to Conference: Sociological Society of Ireland – Waterford, by Dr 
Teresa Whitaker 
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3.5 Publications and Submissions by NACD 
 
NACD Data Needs Submission Paper to the Department of Community 
Rural and Gaeltacht Affairs. Published on the web only in January 2009. 
 
Drug Use in Ireland & Northern Ireland: Updated Results from the 
2002/2003 Drug Prevalence Survey: Bulletin 1: Updated Confidence   
Intervals.  Published on the web only in February 2009. 
 
Drug Use in Ireland & Northern Ireland: Updated Results from the 
2002/2003 Drug Prevalence Survey: Health Board (Ireland) and Health and 
Social Services Board (Northern Ireland):  Bulletin 2: Updated Confidence 
Intervals. Published on the web only in February 2009. 
 
Drug Use in Ireland & Northern Ireland: Drug Prevalence Survey 2006/2007:             
Regional Drugs Task Force Areas (RDTFs) Results: Bulletin 2: Confidence 
Intervals. Published on the web only in February 2009. 
Drug Use in Ireland and Northern Ireland: 2006/2007 Drug Prevalence 
Survey:   Sedatives or Tranquillisers, and Anti-depressants Results: Bulletin 
6. Published in March 2009. 
Drug Use, Sex Work and the Risk Environment in Dublin. Published in 
May 2009. 
 
Drug Use in Ireland and Northern Ireland: 2006/2007 Drug Prevalence 
Survey: Polydrug Use Results: Bulletin 5. Published in June 2009. 
 
Annual Report 2008.  Published on the web only in June 2009. 
 
The ROSIE Study: Drug Treatment Outcomes in Ireland. Published in June 
2009. 
 
Prevalence of Opiate Use in Ireland 2006: A 3-Source Capture Recapture 
Study. Published in December 2009. 
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Chapter Four 
 
Finance  
 
4.1    Research – Funding Allocations 
(for Research Projects Commissioned in 2009) 
(includes VAT where applicable) 
 
Research Advisory Groups 
  
Risk and Protection Factors for Substance Use among Young People: A 
Comparative Study of Early School Leavers and School Attendees 
(Drafting of Final Report) 
Mr Trutz Hasse       €43,740 
 
Supporting Actions/Activities 
Media Relations 
Montague Communications  €20,091.52                               
 
Total NACD Allocation                  €63,831.52           
  
4.2 NACD Expenditure 
 
An annual budget of €1 million was allocated by the Department of Community, 
Rural and Gaeltacht Affairs towards the operation of the NACD. Seventy per 
cent of the annual budget is allocated to research funding and the remaining 30% 
to general administration. 
 
The figures presented are a description of NACD expenditure on research and 
general administration for 2009.  NACD finance is integrated within the general 
accounts of the Department of Community, Rural and Gaeltacht Affairs. 
 
NACD expenditure on new and existing research projects, including media 
relations, for 2009         €301,518.16 
 
NACD expenditure on general administration, including pay and legal services, 
for 2009           €184,225.69 
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Appendix One 
 
Membership of NACD Committee at 31st December 2009 
 
Chairperson 
Dr Des Corrigan, Visiting Academic, School of Pharmacy and 
Pharmaceutical Sciences, Trinity College 
 
Vice-Chairperson  
Dr Mary Ellen McCann, Academic Appointment 
 
Members 
Mr Tony Barden, HSE South East 
Prof Joe Barry, Academic Appointment 
Mr Denis Bradley, National Voluntary Drugs Sector 
Mr Declan Byrne, Community Sector 
Mr Michael Conroy, Dept. of Community, Rural & Gaeltacht Affairs 
Senator Maria Corrigan, Clinical Psychologist 
Mr Joseph Doyle, National Drug Rehabilitation Implementation 
Committee  
Mr Tony Duffin, National Voluntary Drug Sector 
  Mr Bill Ebbitt, HSE Health Promotion Directorate 
Mr John Garry, Dept. of Justice, Equality & Law Reform 
Dr Eamon Keenan, Consultant Psychiatrist, HSE South Western Area   
Dr Jean Long, Evidence Generation and Knowledge Brokering Unit 
(EGKBU), formerly ADRU, Health Research Board 
Ms Geraldine Luddy, Dept. of Health & Children 
Mr Charles R. Murphy, IAAAC 
Mr Liam O’Brien, Community Sector 
Dr Máirín O’Sullivan, Dept. of Education & Science  
Det. Supt Michael D. O’Sullivan, Garda National Drugs Unit 
 
Retired NACD Members (2009) 
Ms Jackie Blanchfield, VDTN 
Mr Eamon Corcoran, Dept. of Health & Children 
Ms Vivienne Fay, HSE 
Ms Mairéad Kavanagh, VDTN 
Det. Supt. Barry O’Brien, Garda National Drugs Unit 
Ms Mary O’Shea, IAAAC 
Ms Anna Quigley, Community Sector 
 
 
 
  
 - 31 - 
Members of Sub-committees (during 2009) 
(Not sitting on Main Committee) 
 
Consequences 
Dr Hugh Gallagher, HSE 
Dr Suzi Lyons, NHISU, Health Research Board 
Ms Alison O’Reilly, Dept. of Justice, Equality & Law Reform 
Ms Mary O’Shea, Dublin Aids Alliance 
Mr Gabriel Staunton, Dept. of Community, Rural & Gaeltacht Affairs 
 
Early Warning/Emerging Trends 
Ms Marita Kinsella, Dept. of Health & Children 
Ms Niamh Arthur, Irish Medicines Board 
Ms Helen Crosse, Toxicology Department, Beaumont Hospital 
Dr James Gray, Emergency Dept. AMNCH 
Mr Gerry Hayes, Dept. of Justice, Equality & Law Reform 
Dr Richie Maguire, Medical Bureau of Road Safety  
Mr Barry McGreal, Dept. of Justice Equality & Law Reform 
Mr Chris Murphy, Crosscare Drug & Alcohol Programme 
Dr Daniel O’Driscoll, Forensic Science Laboratory 
  Dr Audrey O’Donnell, Forensic Science Laboratory 
Ms Mary O’Reilly, Dept. of Health & Children 
  Ms Noreen Quinn, Dept. of Health & Children 
Mr Liam Regan, State Laboratory  
Det Sergeant Brian Roberts, Garda National Drugs Unit  
  Ms Maria Ryan, Revenue Commissioners    
Dr Bobby Smyth, HSE South Western Area 
Mr Gabriel Staunton, Dept. of Community, Rural & Gaeltacht Affairs  
Ms Siobhan Stokes, Drug Treatment Centre Board   
Ms Gillian Treacy, Dept. of Health & Children   
Dr Joe Tracey, Toxicology Department, Beaumont Hospital 
Ms Fiona Walsh, HSE Western Area 
 
Prevalence  
Mr Eddie Arthurs, Dept. of Community, Rural & Gaeltacht Affairs 
Mr Barry McGreal, Dept. of Justice, Equality & Law Reform 
Dr Bobby Smyth, HSE South Western Area 
 
Prevention 
Mr Robbie Breen, Dept. of Health & Children 
Ms Mary Johnston, Walk Tall Programme Support Services 
Ms Ruby Morrow, Church of Ireland College of Education 
Ms Dairearca Ní Neill, Dept. of Community, Rural & Gaeltacht Affairs  
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Ms Clare O’Reilly, Dept. of Health & Children 
Ms Mary O’Shea, Dublin Aids Alliance 
  
Treatment / Rehabilitation 
Mr Alan Bell, Dept. of Health & Children 
Ms Elaine Butler, Homeless Agency   
Mr Paul Conlon, Coolmine Therapeutic Community 
Ms Miriam Conway, FÁS Community Services 
Ms Frances Nangle-Connor, Irish Prison Service 
Ms Anna May Harkin, Dept. of Health & Children 
Mr Seamus Hempenstall, Dept. of Education & Science 
Dr Suzi Lyons, NHISU, Health Research Board 
Ms Siobhan Maher, Family Support Network  
Mr Tim McCarthy, Dept. of Health & Children 
Ms Dairearca Ní Neill, Dept. of Community, Rural & Gaeltacht Affairs 
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Appendix Two 
 
Table of Sub-Committee Membership at 31st December 2009 
 
    Consequences EWET Prevalence Prevention Treatment 
Dr Des 
Corrigan 
Visiting Academic, School of 
Pharmacy and Pharmaceutical 
Sciences, Trinity College 
     
Dr Mary Ellen 
McCann 
Academic Appointment      
Prof Joe Barry  Academic Appointment      
Mr Bill Ebbitt Health Service Executive      
Senator Maria 
Corrigan  
Clinical Psychologist      
Mr Declan 
Byrne 
Community Sector      
Mr Tony Duffin National Voluntary Drug Sector      
Dr Eamon 
Keenan 
Consultant Psychiatrist, HSE 
South Western Area   
    
Dr Jean Long EGKBU, Health Research Board      
Ms Geraldine 
Luddy 
Department of Health and 
Children 
     
Mr Joseph 
Doyle 
National Drug Rehabilitation 
Implementation Committee  
         
Det Supt 
Michael 
D.O’Sullivan 
 
Garda National Drugs Unit      
Mr Liam 
O'Brien 
Community Sector           
Mr Tony 
Barden 
HSE South East Region           
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    Consequences EWET Prevalence Prevention Treatment 
Mr Charles R. 
Murphy 
IAAAC      
Dr Máirín 
O'Sullivan 
Department of Education and 
Science 
     
Ms Alison 
Reilly 
Department of Justice, Equality 
and Law Reform  
    
Ms Mary 
O’Shea 
Dublin Aids Alliance      
Dr Suzi Lyons NHISU, Health Research Board      
Dr Hugh 
Gallagher 
HSE      
Mr Gabriel 
Staunton 
Department of Community 
Rural and Gaeltacht Affairs   
   
Ms Marita 
Kinsella 
Chief Pharmacist, Department of 
Health and Children 
     
Dr Joe Tracey 
Toxicology Department 
Beaumont Hospital 
     
Dr Audrey 
O’Donnell 
Forensic Science Laboratory      
Dr James Gray 
Emergency Department 
AMNCH 
     
Ms Gillian 
Treacy 
Department of Health and 
Children 
     
Mr Gerry Hayes 
Department of Justice, Equality 
and Law Reform 
     
Det Sergeant 
Brian Roberts 
Garda National Drugs Unit      
Ms Mary 
O’Reilly 
Department of Health and 
Children 
     
Mr Liam Regan State Laboratory      
Dr Daniel 
O'Driscoll 
Forensic Science Laboratory      
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    Consequences EWET Prevalence Prevention Treatment 
Ms Noreen 
Quinn 
Department of Health and 
Children 
     
Ms Helen 
Crosse 
Toxicology Department 
Beaumont Hospital 
     
Dr Bobby 
Smyth 
HSE, South Western Area      
Dr Richie 
Maguire 
Medical Bureau of Road Safety      
Ms Maria Ryan Revenue Commissioners      
Ms Niamh 
Arthur 
 
Irish Medicines Board      
Ms Fiona Walsh 
 
HSE Western Area      
Ms Siobhan 
Stokes 
Drug Treatment Centre Board     
 
 
 
Mr Chris 
Murphy 
Crosscare Drug and Alcohol 
Programme 
     
Mr Barry 
McGreal 
Department of Justice, Equality 
and Law Reform 
        
Mr Eddie 
Arthurs 
Department of Community, 
Rural and Gaeltacht Affairs 
       
Mr Robbie 
Breen 
Department of Health and 
Children 
     
Ms Ruby 
Morrow 
Church of Ireland College of 
Education 
     
Ms Mary 
Johnston 
Walk Tall Programme Support 
Services 
     
Ms Clare 
O’Reilly 
Department of Health and 
Children 
     
Ms Dairearca Ní 
Neill 
Department of Community 
Rural and Gaeltacht Affairs 
     
Ms Frances 
Nangle-Connor 
Irish Prison Service      
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    Consequences EWET Prevalence Prevention Treatment 
Mr Alan Bell 
Department of Health and 
Children 
     
Mr Paul Conlon 
Coolmine Therapeutic 
Community 
     
Mr Seamus 
Hempenstall 
Department of Education and 
Science 
     
 
Mr Tim 
McCarthy 
Department of Health and 
Children 
    
 
 
 
Ms Elaine 
Butler 
The Homeless Agency      
Ms Miriam 
Conway 
FÁS Community Services      
Ms Siobhan 
Maher 
Family Support Network      
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Appendix Three 
 
Actions Required of the NACD under the National Drugs Strategy 
2001-2008 
  
In the National Drugs Strategy 2001-2008, the NACD was requested to undertake 
the following actions. 
 
98 To carry out studies on drug misuse amongst the at risk groups 
identified e.g. Travellers, prostitutes, the homeless, early school leavers 
etc. including de-segregation of data on these groups. It is essential 
that the individuals and groups most affected by drug misuse and 
those involved in working to reduce, treat and prevent drug misuse 
have immediate access to relevant statistical information.  
 
99 To commission further outcome studies, within the Irish setting to 
establish the current impact of methadone treatment on both 
individual health and on offending behaviour. Such studies should be 
an important tool in determining the long term value of this treatment.  
 
100 To conduct research into the effectiveness of new mechanisms to 
minimise the sharing of equipment e.g. non-reusable syringes, mobile 
syringe exchange facilities etc. to establish the potential application of 
new options within particular cohorts of the drug using population i.e. 
amongst younger drug misusers, within prisons etc.  
 
 
